Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling

J Immunol. 2019 Aug 15;203(4):1055-1063. doi: 10.4049/jimmunol.1801660. Epub 2019 Jul 10.

Abstract

Full T cell activation depends on stimulation of the TCR in conjunction with a costimulatory receptor. The involvement of costimulatory molecules is potent, and a mechanistic understanding of how downstream signaling is regulated is required to fully understand T cell responsiveness. In this study, a proteomic approach was taken to identify the interactomes of the coreceptors CD2 and CD28. These coreceptors are both positive regulators of T cell activation, but CD28 less potently induces TCR-proximal signaling. C-terminal Src kinase (CSK), a negative regulator of TCR signaling, was identified as a specific and direct interactor only of activated CD28. CSK is recruited to CD28 upon T cell activation, and the in vitro kinase activity of CSK is enhanced in the presence of phosphorylated CD28. Interruption of the CSK/CD28 interaction prior to TCR/CD28 costimulation induces a signaling response which mimics the more potent CD2-induced TCR-proximal pathway activation. Thus, CD28 functions as a novel adaptor protein for CSK, and CSK regulates signaling downstream of CD28.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD28 Antigens / immunology*
  • CD28 Antigens / metabolism
  • CSK Tyrosine-Protein Kinase / immunology*
  • CSK Tyrosine-Protein Kinase / metabolism
  • Cells, Cultured
  • Humans
  • Lymphocyte Activation / immunology*
  • Signal Transduction / immunology*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism

Substances

  • CD28 Antigens
  • CSK Tyrosine-Protein Kinase
  • CSK protein, human